Similar articles

• Inhibition by digoxin and SC4453 of (Na+ + K+)-ATPase prepared from human heart, guinea-pig heart and guinea-pig brain.

  Godfraind T, Tona Lutete DN. Godfraind T, et al. Eur J Pharmacol. 1979 Dec 20;60(4):329-36. doi: 10.1016/0014-2999(79)90237-1. Eur J Pharmacol. 1979. PMID: 230981
• Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.

  Akera T, Ng YC, Shieh IS, Bero E, Brody TM, Braselton WE. Akera T, et al. Eur J Pharmacol. 1985 May 8;111(2):147-57. doi: 10.1016/0014-2999(85)90751-4. Eur J Pharmacol. 1985. PMID: 2990948
• Sensitivity to cardiac glycosides of (Na + K) ATPase prepared from human heart, guinea-pig heart and guinea-pig brain.

  De Pover A, Godfraind T. De Pover A, et al. Arch Int Pharmacodyn Ther. 1976 Jun;221(2):339-41. Arch Int Pharmacodyn Ther. 1976. PMID: 134678 No abstract available.
• The biphasic action of cardiac glycosides on the Na+, K+-pump and its relevance in the treatment of heart failure.

  Godfraind T. Godfraind T. Eur Heart J. 1982 Dec;3 Suppl D:53-7. Eur Heart J. 1982. PMID: 6297911 Review. No abstract available.
• Role of the Na+K+-ATPase in the cardiotonic action of cardiac glycosides.

  Schwartz A, Grupp G, Wallick E, Grupp IL, Ball WJ Jr. Schwartz A, et al. Prog Clin Biol Res. 1988;268B:321-38. Prog Clin Biol Res. 1988. PMID: 2851810 Review.